Indian pharma sector to grow 9-11% in FY26: From Lupin to Max Healthcare—Top 5 stock picks by Motilal Oswal for 2025 | Stock Market News
Source: Live Mint The Indian pharma industry is likely to grow at 9-11% in FY26 (as per Crisil Report), led by price hike and new launches in domestic market and rise in export demand from regulated markets. The Government of India has introduced PLI scheme for pharma industry to promote Make-in-India, wherein ~18-20% of imported…